Clinical trial
A Study for Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine…
NCT00292461 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00292461 |
|---|---|
| Title | A Study for Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine (Lamictal) for Subjects With Refractory Simple Partial, Complex Partial or Partial With Secondary Generalized Seizures |
| Official title | A Study for Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine (Lamictal) for Subjects With Refractory Simple Partial, Complex Partial or Partial With Secondary Generalized Seizures |
| Lead sponsor | Eisai Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Epilepsy |
| Intervention type | Drug |
| Interventions | Zonisamide, Lamotrigine |
| Enrollment | 64 |
| Start date | Mar 1, 2006 |
| Primary completion | Aug 1, 2009 |
| Completion | Sep 1, 2009 |
| First posted | Feb 16, 2006 |
| Last update posted | May 20, 2013 |
| Countries | China |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: